First-line Treatment of Metastatic Pancreatic Cancer With Nab-paclitaxel and Gemcitabine

NCT02564146 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

325

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Cancer
Adenocarcinoma of the Pancreas

Interventions

DRUG: nab-paclitaxel and gemcitabine
DRUG: gemcitabine mono and nab-paclitaxel and gemcitabine

Sponsor

AIO-Studien-gGmbH

Collaborators

[object Object]
[object Object]